MedTrace Logo

Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias

NCT01151527 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 269

Last updated 2015-09-09

No results posted yet for this study

Summary

We hypothesize that a peripheral blood biomarker or biological signature (gene or protein expression pattern) of idiopathic interstitial pneumonias (IIPs) will simplify and improve the accuracy of diagnosis of IIP and diagnose individuals at an earlier, more treatable, stage of their disease.

Conditions

  • Idiopathic Interstitial Pneumonias

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Jewish Health

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Mark P Steele, MD · Duke University

  • David A Schwartz, MD · National Jewish Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151527 on ClinicalTrials.gov